GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
M

Meribank Biotech Co 4724.TWO · TWD

N/A · Taipei Exchange · 🇹🇼 Taiwan

Compare

8.77

-1.24%

Close of 9 Nov 2026, in TWD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in TWD, from our data supplier.

FY2025

Revenue

TWD 471.8m

FY2019FY2025

Net income

−TWD 81.5m

FY2019FY2025

Free cash flow

TWD 84.6m

FY2019FY2025

Shareholders' equity

TWD 1.25bn

FY2019FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019
RevenueTWD 471.8mTWD 366.4mTWD 234.3mTWD 180.1mTWD 163.1mTWD 194.4mTWD 160.9m
Gross profitTWD 357.6mTWD 193.9mTWD 138.9mTWD 94.8mTWD 90.1mTWD 115.1mTWD 93.0m
Research and developmentTWD 31.3mTWD 35.9mTWD 35.5mTWD 25.9mTWD 16.1mTWD 6.4mTWD 4.9m
Operating income−TWD 47.3m−TWD 86.7m−TWD 123.2m−TWD 109.8m−TWD 97.2m−TWD 70.1m−TWD 57.4m
Net income−TWD 81.5m−TWD 94.7m−TWD 125.3m−TWD 102.1m−TWD 99.2m−TWD 54.5m−TWD 59.9m
Diluted earnings per share-0.93-1.08-1.99-1.63-1.13-0.62-0.68

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Total assetsTWD 2.88bnTWD 2.68bnTWD 1.06bnTWD 846.3mTWD 947.3mTWD 730.0mTWD 693.1m
Cash and short-term investments—TWD 165.1mTWD 399.5mTWD 207.9mTWD 286.3mTWD 97.3mTWD 104.6m
Total liabilitiesTWD 1.62bnTWD 1.46bnTWD 390.8mTWD 372.5mTWD 361.3mTWD 347.3mTWD 258.7m
DebtTWD 155.4mTWD 942.8mTWD 34.0mTWD 45.8mTWD 53.0mTWD 69.9mTWD 18.7m
Shareholders' equityTWD 1.25bnTWD 1.21bnTWD 661.7mTWD 471.2mTWD 586.0mTWD 382.6mTWD 434.4m
Shares outstanding88m88m63m63m88m88m88m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Cash from operationsTWD 89.5m−TWD 38.1m−TWD 29.7m−TWD 41.3m−TWD 23.0m−TWD 17.7m−TWD 3.7m
Capital spending−TWD 4.9m−TWD 344.2m−TWD 6.7m−TWD 4.2m−TWD 7.5m−TWD 7.5m−TWD 5.3m
Free cash flowTWD 84.6m−TWD 382.3m−TWD 36.4m−TWD 45.6m−TWD 30.5m−TWD 25.3m−TWD 9.0m

Latest quarters

By quarter end

Jun 2025Dec 2024Jun 2024Dec 2023Jun 2023Dec 2022Jun 2022
RevenueTWD 250.4mTWD 236.1mTWD 130.3mTWD 131.3mTWD 103.1mTWD 101.5mTWD 78.7m
Gross profitTWD 116.3mTWD 112.2mTWD 81.7mTWD 79.3mTWD 59.6mTWD 51.8mTWD 43.0m
Operating income−TWD 24.8m−TWD 40.9m−TWD 47.0m−TWD 65.0m−TWD 58.1m−TWD 58.3m−TWD 51.5m
Net income−TWD 19.1m−TWD 47.8m−TWD 46.9m−TWD 65.6m−TWD 59.8m−TWD 51.4m−TWD 50.7m
Diluted earnings per share-0.22-0.54-0.53-1.04-0.95-0.82-0.81
Cash from operationsTWD 111.0m—−TWD 38.0m−TWD 17.0m−TWD 11.0m−TWD 24.0m−TWD 16.0m
Capital spending−TWD 3.0m−TWD 16.0m−TWD 231.0m−TWD 1.0m−TWD 4.0m−TWD 2.0m−TWD 2.0m
Free cash flowTWD 108.0m—−TWD 269.0m−TWD 18.0m−TWD 15.0m−TWD 26.0m−TWD 18.0m
Total assetsTWD 2.83bnTWD 2.68bnTWD 1.22bnTWD 1.06bnTWD 771.5mTWD 846.3m—
Cash and short-term investmentsTWD 136.2mTWD 165.1mTWD 165.8mTWD 399.5mTWD 169.6mTWD 207.9m—
DebtTWD 267.0mTWD 241.0mTWD 195.4mTWD 38.5mTWD 21.2mTWD 21.6m—
Shareholders' equityTWD 1.20bnTWD 1.21bnTWD 609.7mTWD 661.7mTWD 406.2mTWD 471.2m—

Financial ratios

Data as of 4 Nov 2026

FY2025FY2024FY2023FY2022FY2021FY2020
Gross margin75.8%52.9%59.3%52.6%55.2%59.2%
Operating margin-14.0%-24.8%-55.1%-53.8%-60.1%-27.6%
Net margin-17.3%-25.8%-53.5%-56.7%-60.8%-28.0%
Return on equity-6.5%-7.9%-18.9%-21.7%-16.9%-14.2%
Return on assets-2.8%-3.5%-11.8%-12.1%-10.5%-7.5%
Free cash flow yield11.8%38.4%-4.0%-6.5%——
Revenue growth28.7%56.4%30.1%10.5%-16.1%20.8%
Earnings growth-14.0%-24.4%22.7%3.0%82.1%-9.1%
Current ratio1.90x1.69x4.49x3.60x4.79x2.58x
Debt to equity0.12x0.20x0.06x0.09x0.06x0.05x
Equity ratio43.4%45.0%62.3%55.7%61.9%52.4%
Interest coverage-2.85x-8.49x-152.42x-98.30x-87.09x-72.39x
R&D as a share of sales6.6%9.8%15.1%14.4%9.9%3.3%
Buybacks as a share of market value0.0%-39.8%-0.2%———

Growth per year

Compound annual rate

3 years5 years10 years
Revenue37.8%19.4%—
Operating income-24.5%-7.6%—
Net income-7.3%8.4%—

Average margins

Over each period

1 year3 years5 years10 years
Gross margin65.8%62.7%61.5%—
Operating margin-16.0%-29.3%-33.2%—
Net margin-21.0%-32.2%-34.6%—

Valuation history

At each fiscal year end

FY2025FY2024FY2023
Price to earnings-17.7-26.0-18.9
Price to sales3.06.710.1

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.